Buscar
01/09/2021
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
Tijms, BM, Gobom, J, Teunissen, C, Dobricic, V, Tsolaki, M, Verhey, F, Popp, J, Martinez-Lage, P, Vandenberghe, R, Lleo, A, Molinuevo, JL, Engelborghs, S, Freund-Levi, Y, Froelich, L, Bertram, L, Lovestone, S, Streffer, J, Vos, S, Blennow, K, Scheltens, P, Zetterberg, H, Visser, PJ, ADNI. CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals. Proteomes. 2021; 9(3)DOI:10.3390/proteomes9030036. PMID:34449748. IF:(Q/D).
01/09/2021
Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain
Ledreux, A, Thomas, S, Hamlett, ED, Trautman, C, Gilmore, A, Hager, ER, Paredes, DA, Margittai, M, Fortea, J, Granholm, AC. Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain. Journal of Clinical Medicine. 2021; 10(17)DOI:10.3390/jcm10173931. PMID:34501378. IF:4.964(Q2/4D).
01/09/2021
Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes
Horta-Barba, A, Pagonabarraga, J, Martinez-Horta, S, Busteed, L, Pascual-Sedano, B, Illan-Gala, I, Marin-Lahoz, J, Aracil-Bolanos, I, Perez-Perez, J, Sampedro, F, Bejr-Kasem, H, Kulisevsky, J. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes. JOURNAL OF NEUROLOGY. 2021; 268(9)DOI:10.1007/s00415-021-10511-y. PMID:33704556. IF:6.682(Q1/2D).
01/09/2021
Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome
Montal, V, Barroeta, I, Bejanin, A, Pegueroles, J, Carmona-Iragui, M, Altuna, M, Benejam, B, Videla, L, Fernandez, S, Padilla, C, Aranha, MR, Iulita, MF, Vidal-Pineiro, D, Alcolea, D, Blesa, R, Lleo, A, Fortea, J. Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. ANNALS OF NEUROLOGY. 2021; 90(3)DOI:10.1002/ana.26178. PMID:34309066. IF:11.274(Q1/1D).
19/08/2021
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
Solana, E, Martinez-Heras, E, Montal, V, Vilaplana, E, Lopez-Soley, E, Radua, J, Sola-Valls, N, Montejo, C, Blanco, Y, Pulido-Valdeolivas, I, Sepulveda, M, Andorra, M, Berenguer, J, Villoslada, P, Martinez-Lapiscina, EH, Prados, F, Saiz, A, Fortea, J, Llufriu, S. Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-96132-x. PMID:34413373. IF:4.997(Q2/3D).
01/08/2021
Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome
de Asua, DR, Mayer, MA, Ortega, MD, Borrel, JM, Bermejo, TD, Gonzalez-Lamuno, D, Manso, C, Moldenhauer, F, Carmona-Iragui, M, Huls, A, Sherman, SL, Strydom, A, de la Torre, R, Dierssen, M, Spanish Trisomy 21 Res Soc COVID-1. Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome. Journal of Clinical Medicine. 2021; 10(16)DOI:10.3390/jcm10163748. PMID:34442043. IF:4.964(Q2/4D).